If, at the university level, you can really develop an important expertise with lots of Ph.D.s and professors, you can do amazing research.
Basic research right now, first and foremost, is already public research, not only in Canada but all around the world. Basically this is what is feeding the beginning of the pipelines of most drug companies. They just acquire some of the promising molecules one can find and bring them into the pipeline.
The problem with that is what we are seeing right now, namely drug companies externalizing more and more research. That in itself is not really a bad thing because we know that innovation happens—with smaller biotech companies, for example—but the problem is why then do we still need the major drug companies in all of this in order to commercialize the product—